This is true not only in cancer but also in the non-cancerous PIK3CA-related overgrowth spectrum (PROS) of congenital disorders caused by an identical spectrum of activating PIK3CA mutations as in cancer (Canaud et al, 2023; Madsen et al, 2018). Here, PIK3CA is linked to cancer.